Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTIS: Octreotide for Nutritional Recovery in Esophageal/Gastric Cancer Surgery
NCT04871204Phase 2Completed
- Start
- Jun 2021
- Primary completion
- Feb 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Octreotide long-acting injection in esophageal cancer, gastric cancer (GC). Started Jun 2021; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
esophageal cancergastric cancer (GC)
Beyond the preview
Go deeper on NCT04871204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871204.